{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:36:51Z","timestamp":1789522611213,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T00:00:00Z","timestamp":1323043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T00:00:00Z","timestamp":1323043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep00180","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T14:26:02Z","timestamp":1323095162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy"],"prefix":"10.1038","volume":"1","author":[{"given":"Takuma","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh-ichi","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ishiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Aburatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanri","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,5]]},"reference":[{"key":"BFsrep00180_CR1","unstructured":"Zaloudek, C. & Hendrickson, M. R. Mesenchymal tumors of the uterus, in Kurman RJ. (ed): Blaustein's Pathology of the Female Genital Tract (ed 5). New York, Springer-Verlag 561\u2013578 (2002)."},{"key":"BFsrep00180_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1006\/gyno.1996.0185","volume":"62","author":"A Gadducci","year":"1996","unstructured":"Gadducci, A., et al. Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol. Oncol. 62, 25\u201332 (1996).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep00180_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0959-8049(97)00040-3","volume":"33","author":"R Nordal","year":"1997","unstructured":"Nordal, R. & Thoresen, S. Uterine sarcomas in Norway 1956\u20131992: incidence, survival and mortality. Eur. J. Cancer 33, 907\u2013311 (1997).","journal-title":"Eur. J. Cancer"},{"key":"BFsrep00180_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","volume":"93","author":"SE Brooks","year":"2004","unstructured":"Brooks, S. E., Zhan, M., Cote, T. & Baquet, C. R. Surveillance, epidemiology and end results analysis of 2677 cases of uterine sarcoma 1989\u20131999. Gynecol. Oncol. 93, 204\u2013208 (2004).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep00180_CR5","first-page":"295","volume":"28","author":"KE Dusenbery","year":"2005","unstructured":"Dusenbery, K. E., Potish, R. A., Argenta, P. A. & Judson, P. L. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus. Am. J. Clin. Oncol. 28, 295\u2013300 (2005).","journal-title":"Am. J. Clin."},{"key":"BFsrep00180_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ygyno.2005.08.010","volume":"100","author":"TI Wu","year":"2006","unstructured":"Wu, T. I., et al. Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol. Oncol. 100, 166\u2013172 (2006).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep00180_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/cncr.20521","volume":"101","author":"MM Leitao","year":"2004","unstructured":"Leitao, M. M., et al. Tissue microarray immunohistochemical expression of estrogen, progesterone and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101, 1455\u20131462 (2004).","journal-title":"Cancer"},{"key":"BFsrep00180_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1053\/j.seminoncol.2004.07.017","volume":"31","author":"EA Perez","year":"2004","unstructured":"Perez, E. A., Pusztai, L. & Van de Vijver, M. Improving patient care through molecular diagnostics. Semin. Oncol. 31, 14\u201320 (2004).","journal-title":"Semin. Oncol."},{"key":"BFsrep00180_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11912-008-0077-9","volume":"10","author":"JF Lin","year":"2008","unstructured":"Lin, J. F. & Slomovitz, B. M. Uterine sarcoma. Curr. Oncol. Rep. 10, 512\u2013518 (2008).","journal-title":"Curr. Oncol. Rep."},{"key":"BFsrep00180_CR10","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","volume":"10","author":"F Amant","year":"2009","unstructured":"Amant, F., Coosemans, A., Debiec-Rychter, M., Timmerman, D. & Vergote, I. Clinical management of uterine sarcomas. Lancet Oncol. 10, 1188\u20131198 (2009).","journal-title":"Lancet Oncol."},{"key":"BFsrep00180_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2559.2005.02292.x","volume":"48","author":"M Miettinen","year":"2006","unstructured":"Miettinen, M. & Fetsch, J. F. Evaluation of biological potential of smooth muscle tumours. Histopathology 48, 97\u2013105 (2006).","journal-title":"Histopathology"},{"key":"BFsrep00180_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm.1978","volume":"15","author":"T Muchamuel","year":"2009","unstructured":"Muchamuel, T., et al. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nature Med. 15, 781\u2013788 (2009).","journal-title":"Nature Med."},{"key":"BFsrep00180_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/1074-7613(94)90043-4","volume":"1","author":"L Van Kaer","year":"1994","unstructured":"Van Kaer, L. et al. Altered peptidase and viral-specifi c T cell response in LMP2 mutant mice. Immunity 1, 533\u2013541 (1994).","journal-title":"Immunity"},{"key":"BFsrep00180_CR14","first-page":"24","volume":"62","author":"T Hayashi","year":"2002","unstructured":"Hayashi, T. & Faustman, D. L. Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice. Cancer Res. 62, 24\u201327 (2002).","journal-title":"Cancer Res"},{"key":"BFsrep00180_CR15","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1038\/sj.onc.1209434","volume":"25","author":"T Hayashi","year":"2006","unstructured":"Hayashi, T., Kobayashi, Y., Kohsaka, S. & Sano, K. The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2. Oncogene 25, 4016\u20134026 (2006).","journal-title":"Oncogene"},{"key":"BFsrep00180_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.4049\/jimmunol.173.2.1103","volume":"173","author":"J Marques","year":"2004","unstructured":"Marques, J., Brucet, M., Lloberas, J. & Celada, A. STAT1 regulate lipopolysaccharide- and TNF-\u03b1- dependent expression of transporter associated with antigen processing 1 and low molecular mass polypeptide 2 genes in macrophages by distinct mechanisms. J. Immunol. 173, 1103\u20131110 (2004).","journal-title":"J. Immunol."},{"key":"BFsrep00180_CR17","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.1073\/pnas.0401593101","volume":"101","author":"N Sizemore","year":"2004","unstructured":"Sizemore, N., et al. Inhibitor of \u03baB kinase is required to activate a subset of interferon-\u03b3-stimulated genes. Proc. Natl. Acad. Sci. USA 101, 7994\u20137998 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep00180_CR18","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1128\/MCB.00611-08","volume":"28","author":"A Moschonas","year":"2008","unstructured":"Moschonas, A., et al. CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-\u03baB and of NF-\u03baB-mediated de novo synthesis of IRF-1. Mol. Cell Biol. 28, 6208\u20136222 (2008).","journal-title":"Mol. Cell Biol."},{"key":"BFsrep00180_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/376167a0","volume":"376","author":"AA Beg","year":"1995","unstructured":"Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-\u03baB. Nature 376, 167\u2013170 (1995).","journal-title":"Nature"},{"key":"BFsrep00180_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/0-387-24361-5_3","volume":"126","author":"S Parmar","year":"2005","unstructured":"Parmar, S. & Platanias, L. C. Interferons. Cancer Treat. Res. 126, 45\u201368 (2005).","journal-title":"Cancer Treat. Res."},{"key":"BFsrep00180_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Rev. Immunol. 5, 375\u2013386 (2005).","journal-title":"Nature Rev. Immunol."},{"key":"BFsrep00180_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/35077225","volume":"411","author":"P Blume-Jensen","year":"2001","unstructured":"Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355\u2013365 (2001).","journal-title":"Nature"},{"key":"BFsrep00180_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1082596","volume":"300","author":"A Bardelli","year":"2003","unstructured":"Bardelli, A., et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949 (2003).","journal-title":"Science"},{"key":"BFsrep00180_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal, P. A., et al. A census of human cancer genes. Nature Rev. Cancer 4, 177\u2013183 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFsrep00180_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/431525b","volume":"431","author":"P Stephens","year":"2004","unstructured":"Stephens, P., et al. Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature 431, 525\u2013526 (2004).","journal-title":"Nature"},{"key":"BFsrep00180_CR26","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1126\/science.1096096","volume":"304","author":"Z Wang","year":"2004","unstructured":"Wang, Z., et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304, 1164\u20131166 (2004).","journal-title":"Science"},{"key":"BFsrep00180_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/436792a","volume":"436","author":"DW Parsons","year":"2005","unstructured":"Parsons, D. W., et al. Colorectal cancer: Mutations in a signalling pathway. Nature 436, 792 (2005).","journal-title":"Nature"},{"key":"BFsrep00180_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nm1560","volume":"13","author":"E Hernando","year":"2007","unstructured":"Hernando, E., et al. The AKT-mTOR. pathway plays a critical role in the development of leiomyosarcomas. Nature Med. 13, 748\u2013753 (2007).","journal-title":"Nature Med."},{"key":"BFsrep00180_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ccr.2007.02.007","volume":"11","author":"O Mariani","year":"2007","unstructured":"Mariani, O., et al. JUN. Oncogene Amplification and Overexpression Block Adipocytic Differentiation in Highly Aggressive Sarcomas. Cancer Cell 11, 361\u2013374 (2007).","journal-title":"Cancer Cell"},{"key":"BFsrep00180_CR30","unstructured":"MOTIF Search profiling. http:\/\/motif.genome.jp"},{"key":"BFsrep00180_CR31","unstructured":"NCBI's Conserved Domain Database and Search Service, v2.17 analysis. http:\/\/www.ncbi.nlm.nih.gov\/Structure\/cdd\/cdd.shtml"},{"key":"BFsrep00180_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cancergencyto.2006.01.008","volume":"169","author":"ML Larramendy","year":"2006","unstructured":"Larramendy, M. L., Kaur, S., Svarvar, C., B\u00f6hling, T. & Knuutila, S. Gene copy number profiling of soft-tissue leiomyo- sarcomas by array comparative genome hybridization. Cancer Genet. Cytogen 169, 94\u2013101 (2006).","journal-title":"Cancer Genet. Cytogen"},{"key":"BFsrep00180_CR33","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/modpathol.3800617","volume":"19","author":"C Svarvar","year":"2006","unstructured":"Svarvar, C., et al. Do DNA copy number changes differentiate uterine from non-uterine leiomyosarcomas and predict metastasis? Modern Pathol. 19, 1068\u20131082 (2006).","journal-title":"Modern Pathol."},{"key":"BFsrep00180_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/onc.2009.381","volume":"29","author":"AH Beck","year":"2010","unstructured":"Beck, A. H., et al. Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene 29, 845\u2013854 (2010).","journal-title":"Oncogene"},{"key":"BFsrep00180_CR35","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1182\/blood-2001-11-0142","volume":"101","author":"V Sexl","year":"2003","unstructured":"Sexl, V., et al. Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Blood 101, 4937\u20134943 (2003).","journal-title":"Blood"},{"key":"BFsrep00180_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","volume":"93","author":"SJ Rodig","year":"1998","unstructured":"Rodig, S. J., et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373\u2013383 (1998).","journal-title":"Cell"},{"key":"BFsrep00180_CR37","first-page":"839","volume":"78","author":"A Horiuchi","year":"1998","unstructured":"Horiuchi, A., et al. Reduced expression of calponin h1 in leiomyosarcoma of the uterus. Lab. Invest. 78, 839\u2013846 (1998).","journal-title":"Lab. Invest."},{"key":"BFsrep00180_CR38","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/jnci\/91.9.790","volume":"91","author":"A Hriuchi","year":"1999","unstructured":"Hriuchi, A., Nikaido, T., Taniguchi, S. & Fujii, S. Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma. J. Natl. Cancer Inst. 91, 790\u2013796 (1999).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFsrep00180_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.canlet.2003.08.029","volume":"206","author":"FR Greten","year":"2004","unstructured":"Greten, F. R. & Karin, M. The IKK\/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett. 206, 193\u2013199 (2004).","journal-title":"Cancer Lett."},{"key":"BFsrep00180_CR40","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.bcp.2006.07.032","volume":"72","author":"F Pacifico","year":"2006","unstructured":"Pacifico, F. & Leonardi, A. NF-kappaB in solid tumors. Biochem. Pharmacol. 72, 1142\u20131152 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep00180_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tcb.2003.12.004","volume":"14","author":"ND Perkins","year":"2004","unstructured":"Perkins, N. D. NF-kappaB: tumor promoter or suppressor? Trends Cell Biol. 14, 64\u201369 (2004).","journal-title":"Trends Cell Biol."},{"key":"BFsrep00180_CR42","doi-asserted-by":"publisher","first-page":"11093","DOI":"10.1158\/0008-5472.CAN-07-1576","volume":"67","author":"F Chen","year":"2007","unstructured":"Chen, F. & Castranova, V. Nuclear factor-kappaB, an unappreciated tumor suppressor. Cancer Res. 67, 11093\u201311098 (2007).","journal-title":"Cancer Res."},{"key":"BFsrep00180_CR43","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1074\/jbc.275.7.5238","volume":"275","author":"T Hayashi","year":"2000","unstructured":"Hayashi, T. & Faustman, D. Essential role of human leukocyte antigen-encoded proteasome subunits in NF-\u03baB activation and prevention of tumor necrosis factor-alpha-induced apoptosis. J. Biol. Chem. 275, 5238\u20135247 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFsrep00180_CR44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jcp.20508","volume":"206","author":"HX Wang","year":"2006","unstructured":"Wang, H. X., et al. Proteasome subunit LMP2 is required for matrix metalloproteinase-2 and -9 expression and activities in human invasive extravillous trophoblast cell line. J. Cell Physiol. 206, 616\u2013623 (2006).","journal-title":"J. Cell Physiol."},{"key":"BFsrep00180_CR45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/molehr\/gag088","volume":"9","author":"T Kanamori","year":"2003","unstructured":"Kanamori, T., et al. PEP-19 overexpression in human uterine leiomyoma. Mol. Hum. Reprod. 9, 709\u2013717 (2003).","journal-title":"Mol. Hum. Reprod."},{"key":"BFsrep00180_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0090-8258(03)00274-9","volume":"90","author":"L Wang","year":"2003","unstructured":"Wang, L., et al. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus. Gynecol. Oncol. 90, 402\u2013406 (2003).","journal-title":"Gynecol. Oncol."},{"key":"BFsrep00180_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ijc.21798","volume":"119","author":"SK Ylisaukko-oja","year":"2006","unstructured":"Ylisaukko-oja, S. K., et al. Analysis of fumarate hydratase mutations in a population- based series of early onset uterine leiomyosarcoma patients. Int. J. Cancer 119, 283\u2013287 (2006).","journal-title":"Int. J. Cancer"},{"key":"BFsrep00180_CR48","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/modpathol.2009.96","volume":"10","author":"KR Mittal","year":"2009","unstructured":"Mittal, K. R., et al. Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mod. Pathol. 10, 1303\u20131311 (2009).","journal-title":"Mod. Pathol."},{"key":"BFsrep00180_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1432-1033.1993.tb18123.x","volume":"216","author":"S Frentzel","year":"1993","unstructured":"Frentzel, S., et al. The major histocompatibility complex encoded beta-type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing 20S proteasomes are differentially regulated. Eur. J. Biochem. 216, 119\u201326 (1993).","journal-title":"Eur. J. Biochem."},{"key":"BFsrep00180_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0960-0760(95)00220-0","volume":"56","author":"HS Choi","year":"1996","unstructured":"Choi, H. S., Seol, W. & Moore, D. D. A component of the 26S proteasome binds on orphan member of the nuclear hormone receptor superfamily. J. Steroid Biochem. Biol. 56, 23\u201330 (1996).","journal-title":"J. Steroid Biochem. Biol."},{"key":"BFsrep00180_CR51","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1038\/sj.emboj.7601306","volume":"25","author":"H Zhang","year":"2006","unstructured":"Zhang, H., et al. The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J. 25, 4223\u201333 (2006).","journal-title":"EMBO J."},{"key":"BFsrep00180_CR52","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1093\/emboj\/16.20.6087","volume":"16","author":"EA Reits","year":"1997","unstructured":"Reits, E. A., Benham, A. M., Plougastel, B., Neefies, J. & Trowsdale, J. Dynamics of proteasome distribution in living cells. EMBO J. 16, 6087\u201394 (1997).","journal-title":"EMBO J."},{"key":"BFsrep00180_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal, P. A., et al. A census of human cancer genes. Nature Rev. Cancer 4, 177\u2013183 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFsrep00180_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/156652407779940486","volume":"7","author":"E Lengyel","year":"2007","unstructured":"Lengyel, E., Sawada, K. & Salgia, R. Tyrosine kinase mutations in human cancer. Curr. Mol. Med. 7, 77\u201384 (2007).","journal-title":"Curr. Mol. Med."},{"key":"BFsrep00180_CR55","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1470-2045(07)70104-3","volume":"8","author":"MJ Pajares","year":"2007","unstructured":"Pajares, M. J., et al. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol. 8, 349\u2013357 (2007).","journal-title":"Lancet Oncol."},{"key":"BFsrep00180_CR56","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nm1560","volume":"13","author":"E Hernando","year":"2007","unstructured":"Hernando, E., et al. The AKT-mTOR. pathway plays a critical role in the development of leiomyosarcomas. Nature Med. 13, 748\u2013753 (2007).","journal-title":"Nature Med."},{"key":"BFsrep00180_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ccr.2007.02.007","volume":"11","author":"O Mariani","year":"2007","unstructured":"Mariani, O., et al. JUN. Oncogene Amplifi cation and Overexpression Block Adipocytic Differentiation in Highly Aggressive Sarcomas. Cancer Cell 11, 361\u2013374 (2007).","journal-title":"Cancer Cell"},{"key":"BFsrep00180_CR58","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ng.619","volume":"8","author":"J Barretina","year":"2010","unstructured":"Barretina, J., et al. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nature Genet. 8, 715\u2013721 (2010).","journal-title":"Nature Genet."},{"key":"BFsrep00180_CR59","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nm.2174","volume":"16","author":"F Chibon","year":"2010","unstructured":"Chibon, F., et al. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nature Med. 16, 781\u2013787 (2010).","journal-title":"Nature Med."},{"key":"BFsrep00180_CR60","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1242\/jcs.03008","volume":"119","author":"AV Mikecz","year":"2006","unstructured":"Mikecz, A. V. The nuclear ubiquitin-proteasome system. J. Cell Science 119, 1977\u20131984 (2006).","journal-title":"J. Cell Science"},{"key":"BFsrep00180_CR61","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","volume":"117","author":"JB Swann","year":"2007","unstructured":"Swann, J. B. & Smyth, M. J. Immune surveillance of tumors. J. Clin. Inve. 117, 1137\u20131196 (2007).","journal-title":"J. Clin. Inve."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep00180","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:18:53Z","timestamp":1672978733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep00180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,5]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,12,23]]}},"alternative-id":["BFsrep00180"],"URL":"https:\/\/doi.org\/10.1038\/srep00180","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,5]]},"assertion":[{"value":"20 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}